Republic of Congo Announces Ebola Outbreak, Partners with Merck

The Democratic Republic of Congo’s health ministry has approved the use of a not-yet-licensed Merck vaccine to combat an outbreak of Ebola in the northeast which has killed four people. Clinical trials of the vaccine, rVSV-ZEBOV, last December showed a strong...

MRSA Vaccine Draws Closer to Reality

According to Genengnews.com, “Scientists lead by a team at the NYU Langone Medical Center say they have found out why a particular strain of Staphylococcus aureus, known as HA-MRSA, becomes more deadly than other variations. These new findings open up possible...